CD8A and melanoma: In the present study, we observed that in vivo treatment with IL-15 dramatically promoted the survival and/or proliferation of activated MART-1-TCR+ CD8 T cells, which was associated with a significantly increased antitumor effect, in melanoma-bearing hosts.